Rich Nelson, Sr. Manager, Global Logistics recently discussed the factors which need to be considered for clinical trial sponsors to incorporate Direct-To-Patient (DTP) protocols rapidly, to help navigate the challenges presented by the COVID-19 pandemic.

In the midst of the COVID-19 pandemic, clinical trial sponsors are having to quickly find alternative methods to keep their trials moving forward as challenges arise such as clinical sites having to close, or patients being unable to travel to the sites for safety reasons.